XWELL (XWEL) Stock Price, News & Analysis

Company Overview

XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs. The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.

Key Stats

• Today's Range: $0.99 to $1.04
• 50-Day Range: $0.99 to $1.25
• 52-Week Range: $0.70 to $2.00
• Volume: 206,546 shs
• Average Volume: 13,601 shs
• Market Capitalization: $5.70 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

XWELL Stock Analysis - MarketRank™

XWELL scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for XWELL.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

XWELL has a P/B Ratio of 0.67. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.93% of the float of XWELL has been sold short.

Short Interest Ratio / Days to Cover

XWELL has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in XWELL has recently decreased by 6.74%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

XWELL does not currently pay a dividend.

Dividend Growth

XWELL does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.93% of the float of XWELL has been sold short.

Short Interest Ratio / Days to Cover

XWELL has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in XWELL has recently decreased by 6.74%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: N/A

News Sentiment

XWELL has a news sentiment score of 1.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for XWELL this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, XWELL insiders have not sold or bought any company stock.

Percentage Held by Insiders

13.93% of the stock of XWELL is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 8.67% of the stock of XWELL is held by institutions.

XWEL Stock Analysis - Frequently Asked Questions

How have XWEL shares performed this year?

XWELL's stock was trading at $1.51 on January 1st, 2025. Since then, XWEL stock has decreased by 34.4% and is now trading at $0.99.

How were XWELL's earnings last quarter?

XWELL, Inc. (NASDAQ:XWEL) released its quarterly earnings results on Thursday, August, 14th. The company reported ($0.56) earnings per share (EPS) for the quarter. The company earned $7.69 million during the quarter. XWELL had a negative net margin of 63.18% and a negative trailing twelve-month return on equity of 265.41%.
Read the conference call transcript.

When did XWELL's stock split?

XWELL shares reverse split before market open on Thursday, September 28th 2023.The 1-20 reverse split was announced on Thursday, September 28th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of XWELL?

Shares of XWEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of XWELL own?

Based on aggregate information from My MarketBeat watchlists, some other companies that XWELL investors own include Walt Disney (DIS), AFC Gamma (AFCG), American Lithium (AMLI), BOTS (BTZI), Rolls-Royce Holdings PLC (RYCEY), Meta Platforms (META) and Sunrise Realty Trust (SUNS).

Company Calendar

• Last Earnings: 8/14/2025
• Today: 9/30/2025
• Next Earnings (Estimated): 11/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Personal Services
• Current Symbol: NASDAQ:XWEL
• CIK: 1410428
• Web: www.xwell.com
• Phone: (212) 750-9595
• Fax: 309-410-3967
• Employees: 360
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($4.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$16.85 million
• Net Margins: -63.18%
• Pretax Margin: -61.76%
• Return on Equity: -265.41%
• Return on Assets: -72.67%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.25
• Quick Ratio: 1.19

Sales & Book Value

• Annual Sales: $30.60 million
• Price / Sales: 0.19
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.47 per share
• Price / Book: 0.67

Miscellaneous

• Outstanding Shares: 5,757,000
• Free Float: 4,955,000
• Market Cap: $5.70 million
• Optionable: No Data
• Beta: 1.10